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OBJECTIVES The present study evaluated the impact of recruitable collaterals on regional myocardial
perfusion measured by 99mtechnetium (Tc)-sestamibi single-photon emission computerized
tomography (SPECT) during temporary coronary occlusion and related these estimates to the
coronary wedge pressure and electrocardiographic (ECG) ST-segment changes.
BACKGROUND Clinical variables (angina and ECG changes) and intracoronary flow and pressure recordings
have indicated a protective role of recruitable collaterals on myocardial perfusion during
percutaneous transluminal coronary angioplasty (PTCA).
METHODS Thirty patients (mean age 55 years, SD 9; 20 men) with stable angina pectoris and proximal
nonoccluding single-vessel left anterior descending coronary artery (LAD)-stenosis scheduled
for PTCA were included. Visualization of recruitable collaterals by ipsilateral and contralat-
eral contrast injection, registration of coronary wedge pressure and injection of 99mTc-
sestamibi during 90-s LAD occlusions were undertaken. A rest perfusion study was
performed within four days before PTCA. As an estimate of the severity of regional
hypoperfusion during occlusion, an occlusion/rest count ratio was calculated (mean defect
pixel count during occlusion divided by mean pixel count in identical regions at rest).
RESULTS The scintigraphic occlusion/rest count ratio was higher in patients with recruitable collaterals
(n 5 16), 67 6 11%, compared to patients without collaterals (n 5 14), 60 6 6% (p , 0.05).
The occlusion/rest count ratio correlated with the coronary wedge pressure (R2 5 0.34; p ,
0.001). The occlusion/rest count ratio was lower, 61 6 6%, in patients with ST-segment
elevation (n 5 23) versus 74 6 9% in patients without ST-segment elevation (n 5 7) (p ,
0.0001).
CONCLUSIONS Using 99mTc-sestamibi SPECT imaging during brief episodes of coronary occlusion, the
severity of regional myocardial hypoperfusion was reduced by the presence of recruitable
collaterals in a selected patient population with proximal LAD stenoses. Our results
demonstrate a protective effect of recruitable collaterals on myocardial perfusion during
temporary coronary occlusion. (J Am Coll Cardiol 2000;35:624–32) © 2000 by the
American College of Cardiology
The protective role of coronary collaterals during occlusion
of coronary arteries in humans has been debated for years. In
infarct patients with angiographically verified collaterals, the
extent of myocardial necrosis is smaller compared to pa-
tients without collateral supply, evidenced by biochemical
(1) and scintigraphic estimates of infarct sizes (2–4), and by
less severe regional and global contractile dysfunction (5).
Aneurysm formation has been reported to be less frequent
in patients with collateral supply to the infarct-related artery
(6).
By injecting contrast medium in both the contralateral
and the ipsilateral coronary artery during controlled coro-
nary occlusion by percutaneous transluminal coronary an-
gioplasty (PTCA), Rentrop et al. (7) developed a method
that enabled visualization of collaterals (recruitable collater-
als) that were not visualized during routine angiography
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(spontaneously visible collaterals). The existence of re-
cruitable collaterals has been demonstrated in 30% to 60%
of patients with single-vessel disease (8,9) and has shown
protective effects during controlled coronary occlusion evi-
denced by less occurrence of angina and electrocardio-
graphic changes (9,10) in patients with recruitable collater-
als compared to patients without. None of these studies
included direct estimates of myocardial perfusion.
The primary aim of this study was to evaluate the impact
of recruitable collaterals on regional myocardial perfusion by
99mTc-sestamibi single-photon emission computerized to-
mography (SPECT) during temporary coronary occlusion
in a selected patient population with proximal left anterior
descending coronary artery (LAD)-stenosis undergoing
PTCA.
METHODS
Patient population. To obtain a population with a high
probability of recruitable collaterals, we prospectively in-
cluded patients with angina pectoris, who were admitted for
coronary angioplasty due to angiographically verified prox-
imal (segment 1 or 2) single-vessel nonoccluding LAD
stenosis with a grade of stenosis between 50% and 95% and
an ejection fraction above 50%, assessed by biplane ventricu-
lography, as the frequency of spontaneously visible collater-
als was assumed to be higher in patients with occlusive
coronary disease and in patients who had survived Q-wave
myocardial infarctions. Excluded were patients with 1)
myocardial infarction within three months; 2) previous
anterior Q-wave infarction; 3) previous revascularization
(coronary bypass surgery or PTCA); 4) hemodynamically
significant valvular heart disease; 5) uncontrolled hyperten-
sion defined as resting systolic blood pressure .200 mm Hg
or resting diastolic blood pressure .100 mm Hg; 6)
hypertrophic cardiomyopathy; 7) chronic or paroxysmal
atrial fibrillation or flutter; and 8) left bundle branch block.
Patients continued their usual medication throughout the
study. The study was approved by the local ethical commit-
tee and conducted in accordance with the Helsinki-II
declaration. All patients received verbal and written infor-
mation and gave informed consent before inclusion.
Invasive procedures. COLLATERALS AND GRADE OF STE-
NOSIS. Coronary angioplasty was performed by the percu-
taneous femoral approach by an over-the-wire system. An
8F guiding catheter was used for guidance of the balloon
catheter and a 6F catheter for angiography of the contralat-
eral coronary artery. Before angioplasty, contralateral and
ipsilateral contrast injections were performed to visualize
spontaneously visible collaterals. Cineangiography was con-
tinued until no further opacification of the injected vascular
bed was present. After angioplasty, the balloon catheter was
reintroduced to the site of the treated lesion and the balloon
was reinflated at low pressure (1.5 to 2 bar). After 30 s,
repeat angiograms with first contra- and then ipsilateral
contrast injections were performed to visualize recruitable
collaterals and to ensure total balloon occlusion (7).
Spontaneously visible and recruitable collateral blood
flows were assessed in accordance with the classification
proposed and validated by Rentrop et al. (7): 0: no contrast
filling of the recipient artery; 1: filling of side branches of the
recipient artery; 2: partial filling of the recipient artery; 3:
complete filling of the recipient artery. Patients with grade
2 or 3 collaterals were classified as having collaterals,
whereas patients with grade 0 or 1 were classified as having
no collaterals. Grades of stenosis and the occurrence of
collaterals were evaluated blindly by one experienced an-
giographer by visual analysis.
CORONARY WEDGE PRESSURE. Simultaneously with visual-
ization of recruitable collateral flow, the mean distal coro-
nary occlusion pressure was assessed by a dedicated pressure
transducer (Baxter, the Netherlands). After positioning of
the balloon in the treated lesion, the guide wire was
removed, and it was ascertained that the lumen of the
catheter was fluid-filled and without any air microbubbles.
Balloon inflation at low pressure (1.5 to 2 bars) was
undertaken with simultaneous registration of distal intra-
coronary pressure, which was recorded on graph paper. As
soon as the pressure curve leveled off, approximately 30 s
after balloon inflation, the mean distal coronary pressure
was registered (7,11). Ipsilateral contrast injection was
performed to check complete balloon occlusion.
Mean aortic pressure was measured through the guiding
catheter and registered simultaneously with the coronary
wedge pressure. Heart rate was monitored continuously
during the procedure.
Electrocardiographic changes and chest pain. A 12-lead
ECG was recorded during balloon occlusion and continued
until 30 s after balloon deflation or until disappearance of
any significant electrocardiographic changes. The ST-
segment elevation equal to or exceeding 0.2 mV measured at
the J-point or ST-segment depression equal to or exceeding
0.1 mV measured 80 ms after the J-point were considered as
significant markers of myocardial ischemia.
Patients were asked about chest pain during angioplasty
at every balloon occlusion according to the Borg scale (12).
Abbreviations and Acronyms
AUC 5 area under the curve
LAD 5 left anterior descending coronary
artery
PTCA 5 percutaneous transluminal coronary
angioplasty
SPECT 5 single-photon emission computerized
tomography
99mTc-sestamibi 5 99m-technetium-sestamibi
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A score of 0 indicated no chest pain, and a score of 10
indicated extremely strong chest pain.
Scintigraphy. Studies of regional myocardial perfusion
were performed at rest (within four days before the angio-
plastic procedure) and during low-pressure balloon occlu-
sion of 90 s at the end of the therapeutic procedure.
99m-Technetium-sestamibi (99mTc-sestamibi; Cardiolite,
Dupont, Hertfordshire, UK) was injected as a bolus of
700 MBq 6 10% in an antecubital vein and followed by 10
ml of saline. Image acquisition was performed 1 h after
tracer injection. The SPECT acquisition was carried out
with patients in the supine position using a single-headed
rotating gamma camera (Genesys, ADAC) with a high-
resolution, parallel-holed collimator. Sixty-four projections
of 20 s each were obtained over a noncircular 180° arc,
extending from the 45° right anterior oblique to the 45° left
posterior oblique position. A 20% symmetric energy win-
dow centered on the 140-keV peak was used. Both the
injected dosage of sestamibi and the scintigraphic procedure
during the rest scan were identical to the PTCA procedure.
All projection images were stored on magneto-optic disks in
a 64 3 64 matrix. Filtered backprojection was performed
using a Butterworth filter with a cutoff frequency of 0.35
cycles/pixel, order 5, to reconstruct transverse axial tomo-
grams. No attenuation or scatter correction was used. Raw
data were checked for patient motion. Reorientation of
slices was performed after reconstruction according to the
anatomic axis of the heart. Slices were displayed as short
axis, vertical, and horizontal long axis slices.
Polar maps were automatically generated, and the size of
the PTCA-induced perfusion defects was estimated in
accordance with the Cedar’s-Sinai program (13), in which
the volume-weighted polar maps were compared to gender-
specific normal databases of regional myocardial perfusion
at rest. The severity of the PTCA-induced perfusion defects
was calculated by normalizing pixel counts in the polar maps
obtained in the PTCA study and the rest study to maximum
pixel count. The blackout from the polar map of the PTCA
study was transferred to the polar map obtained at rest, and
the average pixel counts in these blackout areas were divided
to assess an occlusion/rest count ratio, which was taken as an
estimate of the severity of myocardial hypoperfusion in-
duced by the coronary occlusion. All studies were validated
by visual assessment of scintigrams and performed blinded
to all other patient data.
Arterial plasma profile of 99mTc-sestamibi. To evaluate
the amount of recirculating sestamibi at the time of balloon
deflation, arterial blood samples of 1 ml were sampled from
the left femoral artery in 11 consecutive patients every 5 s
during the first 5 min after 99mTc-sestamibi injection with a
dedicated sample collector (Ole Dich Instruments, Den-
mark). All samples were counted as 0.5 ml whole blood
samples the day after collection (Cobra II, Packard). Ra-
dioactivity was corrected for decay and expressed as a
percentage of radioactivity in the blood sample with peak
activity. The amount of sestamibi available for myocardial
uptake was calculated as the area under the curve (AUC) by
numeric integration and by exponential fitting and extrap-
olation to 1-h postinjection (start of imaging).
Statistical analysis. Data were expressed as proportions or
as mean with standard deviations (SD) in normal distrib-
uted data or by median and range in nonparametric distri-
butions. Either the chi-square test or the Fisher exact test
was used for evaluation of differences between proportions.
Differences of mean values in normal distributed data were
assessed by the Student t test and by the Mann-Whitney U
test in nonparametric distributions. Relations between con-
tinuous variables were described by linear regression analy-
ses and expressed as R2 values. All tests were two-tailed, and
p values less than 0.05 were considered significant.
RESULTS
Thirty-six patients were included in the study. Severe
coronary spasm during the PTCA procedure occurred in
two patients, significant patient movement during SPECT
imaging in two patients, progression of the coronary lesion
to a total occlusion between diagnostic angiography and
PTCA in one patient and unintended occlusion of the
balloon in the circumflex territory during sestamibi injection
in one patient with an ostium LAD stenosis. The remaining
30 patients (mean age 55 years, SD 9; 20 men) completed
the study protocol. No complications were induced by the
additional balloon occlusions.
Demographic data. As seen in Table 1, the only significant
difference between patients with (n 5 16) and without
collaterals (n 5 14) was a higher proportion of men in the
group with collaterals. This difference was not related to the
median duration of anginal symptoms, 12 months (5 to
90 months) for women versus 14 months (6 to 60 months)
for men (NS), the occurrence of prior myocardial infarction,
30% of women versus 25% of men (NS), or the median
grade of stenosis, 85% (55% to 95%) for women versus 80%
(70% to 95%) for men (NS). Eight patients had a history of
a prior myocardial infarction, five non-Q-wave anterior
infarctions, two non-Q-wave infarctions with unknown
location, and one Q-wave inferior infarction. Most infarc-
tions were likely to be small as the mean ejection fraction
was normal and did not differ from patients without prior
myocardial infarction, 72% (57% to 91%) versus 75% (60%
to 88%) (NS), respectively.
Invasive procedures. Sixteen patients were treated with
PTCA as the only treatment, 12 patients with PTCA and
stenting, 1 patient with atherectomy and PTCA, and 1
patient was treated with rotablation and PTCA. A median
of four dilations (2 to 7 dilations) were performed per
patient. No differences were observed between patients with
and without collaterals.
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COLLATERALS AND GRADES OF STENOSIS. Baseline an-
giography of the contralateral vessel (right coronary artery)
revealed spontaneously visible collaterals in only one patient
(grade 2). During balloon occlusion 11 patients developed
grade 3 recruitable collaterals, 5 patients grade 2 collaterals,
4 patients grade 1 collaterals, and 10 patients remained
without collateral filling (Fig. 1). Patients with grade 1 or 2
spontaneously visible collaterals during baseline developed a
more evident collateral supply during vessel occlusion.
Accordingly, 16 patients were classified as having recruitable
collaterals (grade 2 or 3) and 14 patients as having no
collateral supply during occlusion (grade 0 or 1).
The median grade of stenosis in vessels receiving re-
cruitable collaterals, 85% (70% to 95%) was significantly
higher than in vessels without collaterals, 75% (55% to
90%), (p , 0.05). Ejection fractions ranged from 57% to
91%, with a mean value of 73 6 10% in patients with
collaterals and 72 6 9% in patients without (NS).
COLLATERALS AND CORONARY WEDGE PRESSURE. The
mean overall coronary wedge pressure was 27 6 11 mm Hg,
range 8 to 57 mm Hg, being significantly higher, 33 6
10 mm Hg, in vessels with angiographically demonstrable
collateral supply versus 21 6 7 mm Hg in those without
(p , 0.001). A coronary wedge pressure above 30 mm Hg
was found in 8 of 16 patients with collateral supply as
opposed to 1 of 14 patients without collateral supply (p ,
0.01). The ratio between the coronary wedge pressure and
the simultaneously measured mean aortic pressure was
0.34 6 0.08 in patients with collaterals versus 0.22 6 0.06
in patients without collaterals (p , 0.001).
HEMODYNAMICS. Mean aortic pressure during balloon oc-
clusion, at which the evaluation of collaterals was per-
formed, was 98 6 15 mm Hg in patients with collaterals
versus 92 6 14 mm Hg in patients without recruitable
collaterals (NS). Mean heart rate during occlusion was 67 6
Figure 1. Change of collateral grade during temporary coronary
occlusion. The collateral grades pre-dilation and during inflation
are given by III: grade 3 collaterals; II: grade 2 collaterals; I: grade
1 collaterals; 0: no collaterals. The number of patients with a
certain collateral grade is shown in the boxes.
Table 1. Demographic Data in 30 Patients with Nonoccluding LAD Stenosis in Relation to the
Occurrence of Recruitable Collaterals
1Collaterals
(n 5 16)
2Collaterals
(n 5 14) p Value
Age, years, mean 6 SD 56 6 8 55 6 10 NS
Gender, male, n (%) 88 43 0.02
Prior MI, n (%) 38 14 NS
AP duration, months, median (range) 12 (5–84) 14 (6–90) NS
AP attacks per week, median (range) 7 (5–25) 10 (5–100) NS (0.06)
CCS class, n
1 4 3
2 7 7
3 5 4 NS
4 0 0
Rest AP, n (%) 38 79 NS (0.06)
Smoking, n (%) 75 79 NS
Hypercholesterolemia, n (%) 63 43 NS
Diabetes, n (%) 13 0 NS
Hypertension, n (%) 6 21 NS
Family history of CAD, n (%) 56 43 NS
Long-acting nitrates, n (%) 50 43 NS
Ca-antagonists, n (%) 19 50 NS
Beta-blockers, n (%) 81 57 NS
$2 antianginal drugs, n (%) 50 50 NS
Acetylsalicylic acid, n (%) 88 79 NS
AP: angina pectoris; CCS: classification of Canadian Cardiological Society; Family history of CAD: $1. generation relative with
CAD; hypercholesterolemia: total se-cholesterol .6 mmol/liter or cholesterol-lowering therapy; hypertension; based on
anamnestic diagnosis; MI: myocardial infarction; smoking: patients who stopped smoking within three years or were currently
smoking.
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9 beats/min in patients with collaterals versus 71 6
14 beats/min in patients without (NS).
Collaterals and ECG changes/chest pain. Two patients
had significant Q-waves at rest, in one patient located in
leads II, III, aVF and in one patient in lead III as the only
location. During the PTCA procedure, 23 patients devel-
oped ST-segment elevation, 3 patients had ST-segment
depression, and 4 patients had no ST changes. The ST-
segment elevation was observed in 56% of patients with
recruitable collaterals versus 100% of patients without col-
laterals (p , 0.01).
Twenty-eight of 30 patients developed angina during the
PTCA procedure with no difference between patients with
and without collaterals. The mean maximal intensity of
chest pain during the procedure as evaluated by the Borg
scale was more pronounced in patients without collaterals
than in patients with collateral supply, 8 6 1 versus 6 6 3
(p , 0.05).
Collaterals and scintigraphy. Twenty-eight of 30 patients
had completely normal regional myocardial perfusion at
rest, of whom 7 patients had a diagnosis of a prior
non–Q-wave myocardial infarction. Two patients had small
areas, 5.7% and 8.3% of the left ventricle, with significant
decrease of regional myocardial perfusion at rest.
By study design the balloon was kept inflated for 90 s
during the balloon occlusion, at which sestamibi was ad-
ministered. In 8 patients the balloon was deflated earlier due
to either severe chest pain (5 patients) or multifocal ven-
tricular extrasystoles (3 patients), representing 2 of 16
patients with collaterals and 6 of 14 patients without
collateral supply (NS). The mean PTCA-defect size in the
entire population was 31 6 10%, range 16% to 46%, while
the mean defect severity estimated as the occlusion/rest
count ratio was 63 6 9%. No differences were found in
mean defect sizes and mean defect severities in patients with
90-s occlusions versus patients with less occlusion time.
Scintigraphy, coronary wedge pressure and recruitable
collaterals. The defect severity during PTCA, estimated as
the mean occlusion/rest count ratio in patients with re-
cruitable collaterals, was 67 6 11% versus 60 6 6% in
patients without collaterals (p , 0.05) (Fig. 2). This
difference in the occlusion/rest count ratio was not due to
differences between groups in regional perfusion at rest in
the LAD territory, as the mean rest/maximum pixel count
ratio was 74 6 6% in patients with collaterals versus 75 6
7% in patients without (p 5 0.69), respectively.
An occlusion/rest count ratio above 70% was only found
in patients with recruitable collaterals, 6 of 16 patients with
collaterals versus 0 of 14 patients without collaterals (p ,
0.05). All patients with an occlusion/rest count ratio above
70% had grade 3 recruitable collaterals. Furthermore, these
6 patients had a mean coronary wedge pressure that was
significantly higher than in 10 patients also demonstrating
collaterals with occlusion/rest count ratios below 70%, the
figures being 41 6 10 mm Hg versus 29 6 8 mm Hg (p ,
0.05).
A significant positive correlation was observed between
the coronary wedge pressure and the severity of hypoperfu-
sion evaluated by the scintigraphic occlusion/rest count ratio
(R2 5 0.34, p , 0.001) (Fig. 3).
The PTCA-defect size was neither correlated with the
coronary wedge pressure nor with the occurrence of re-
cruitable collaterals.
Invasive and noninvasive estimates of myocardial perfu-
sion. The ECG changes were significantly related to the
scintigraphic estimates of myocardial hypoperfusion during
Figure 2. Scintigraphically estimated defect severity during bal-
loon occlusion in patients with and without recruitable collaterals.
Figure 3. Coronary wedge pressure in relation to scintigraphic
defect severity during balloon occlusion.
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PTCA, as the mean occlusion/rest count ratio was 61 6 6%
in patients with ST-segment elevation (n 5 23) versus 74 6
9% in patients with no ST-segment elevation (n 5 7) (p ,
0.0001). Also, ECG changes were correlated to the PTCA-
defect sizes, the mean defect sizes being 33 6 9% (ST
elevation) versus 24 6 7% (no ST elevation) (p , 0.05).
The ECG changes were significantly related to the
coronary wedge pressure, as the mean pressures were 24 6
8 mm Hg in patients with ST-segment elevation (n 5 23)
and 39 6 11 mm Hg in patients without ST-segment
elevation (n 5 7) (p , 0.001).
In Table 2, the relations among ECG changes and the
scintigraphic severity of the induced perfusion defects, the
coronary wedge pressure, and the occurrence of angio-
graphically visible recruitable collaterals are shown. All three
parameters were significantly related to the occurrence of
RST elevation, with 99mTc-sestamibi SPECT as the most
accurate method, with an accuracy of 90%, while the
coronary wedge pressure and the recruitable collateral status
correctly predicted RST elevation in 80% and 70% of cases,
respectively.
Maximal severity of chest pain during the PTCA proce-
dure was not correlated to the scintigraphically estimated
defect size (R2 5 0.06, p 5 0.22), the occlusion/rest count
ratio (R2 5 0.07, p 5 0.17), or to the coronary wedge
pressure (R2 5 0.0001, p 5 0.96).
Arterial plasma profile of 99mTc-sestamibi. Arterial peak
concentration was reached in mean 25 s postinjection (Fig.
4). The procentual parts of the AUC during the first 1, 2, 3,
4, and 5 min in relation to the AUC from injection to
imaging were as follows: 55%, 76%, 85%, 90% and 93%. At
90 s postinjection, the estimated value was 68%.
DISCUSSION
In this study, we were able to demonstrate an overall
protective role of recruitable collaterals on regional myocar-
dial perfusion evaluated by 99mTc-sestamibi SPECT during
controlled coronary occlusion of the LAD. A scintigraphic
index, the occlusion/rest count ratio, was used. A ratio
above 70% was only seen in patients with recruitable
collaterals. This threshold value predicted the occurrence of
ECG RST elevation with an accuracy of 90%. In addition,
the ratio was significantly correlated to the coronary wedge
pressure.
Figure 4. Time-activity curve for 99mTc-sestamibi in arterial blood after venous bolus injection.
Table 2. Relation Between Electrocardiographic Signs of Severe Ischemia During PTCA and
Three Variables for Assessing the Recruitable Collateral Extent
RST Elevation
Absent (n 5 7)
RST Elevation
Present (n 5 23)
Occlusion/rest count ratio,‡ (n)
.70% 5 1
#70% 2 22
Coronary wedge pressure,* (n)
.30 mm Hg 5 4
#30 mm Hg 2 19
Recruitable collaterals,† (n)
Grade 2 or 3 7 9
Grade 0 or 1 0 14
Three of seven patients with absent RST elevation had ST depression. *p , 0.05. †p , 0.01. ‡p , 0.001.
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Scintigraphic estimated perfusion and collaterals. Con-
firming previous studies (14,15) the size of the territory
supplied by the LAD varied greatly between patients, which
might explain that we found no difference in the mean of
perfusion defects in patients with and without recruitable
collaterals. The variation in defect sizes is unlikely to be
caused by methodological problems of perfusion imaging, as
recent studies have found that the area at risk evaluated by
scintigraphy was positively correlated with the release of
biochemical markers of necrosis in patients with acute
myocardial infarction (16) and negatively to the occurrence
of spontaneously visible collaterals during PTCA (17). In
animal studies (18), close agreement between microsphere-
determined collateral flow and the severity of perfusion
defects evaluated by sestamibi SPECT during coronary
occlusion has been demonstrated.
To evaluate the severity of hypoperfusion within abnor-
mally perfused regions, prior studies used different methods
of analysis, employed different ischemic cutoff limits and
reference areas (14,19,20), but no consensus has been
reached. In this study we applied a scintigraphic estimate
that was based on defining the size of the territory with
significant abnormal perfusion during balloon occlusion by
comparison to a validated rest normal database (13). The
activity within that area was compared to the identical area
at rest to obtain an occlusion/rest count ratio. The rationale
for applying this ratio was that of minimizing interindi-
vidual confounding effects of body attenuation of gamma
rays.
In this study, performed in selected patients with proxi-
mal LAD stenoses and preserved left ventricular function,
we demonstrated a protective effect of recruitable collaterals
on myocardial perfusion during temporary coronary occlu-
sion by using the described occlusion/rest ratio. To validate
these results further, we compared our scintigraphic data to
other objective measures of hypoperfusion during balloon
occlusion, the coronary wedge pressure and electrocardio-
graphic changes.
Scintigraphic hypoperfusion and coronary wedge pres-
sure. A significant correlation was found between myocar-
dial hypoperfusion estimated by perfusion imaging and the
coronary wedge pressure: the latter being an invasive epi-
cardial pressure recording distal to a simultaneous coronary
occlusion (7), the former a noninvasive estimate of regional
microcirculation, combining injection of the radioactive
tracer during balloon occlusion and delayed SPECT imag-
ing.
Recently, the evaluation of the protective effects of
recruitable collaterals during temporary coronary occlusion
by intracoronary pressure recordings has been further devel-
oped by Pijls et al. (21), who introduced the term “re-
cruitable fractional collateral blood flow,” defined as a
function of the mean arterial pressure, the coronary wedge
pressure and the central venous pressure during coronary
occlusion. Recruitable fractional collateral blood flow was
found to be a more accurate marker of PTCA-induced
electrocardiographic changes than the coronary wedge pres-
sure alone. To which extent recruitable fractional collateral
blood flow actually was associated with the occurrence of
recruitable collaterals during temporary occlusion was not
determined in the study by Pijls, as contralateral contrast
injection was not undertaken. Although we did not measure
right atrial pressure during balloon occlusion, we were able
to demonstrate a significant correlation between our scinti-
graphic estimate of hypoperfusion and the wedge pressure.
Scintigraphic hypoperfusion and electrocardiographic
changes. The analyses of ECG changes during coronary
occlusion only included the occurrence of ST-segment
changes without taking into account the number of leads or
the magnitude of ST changes. Nevertheless, we found a
significant relation between ST changes and the severity of
hypoperfusion by SPECT imaging. Others found no cor-
relation between the number of leads with electrocardio-
graphic changes and the severity of hypoperfusion evaluated
by sestamibi SPECT during PTCA of the LAD (22).
However, all patients in that study were survivors of an
acute anterior myocardial infarction, and 7 of the 11 patients
had perfusion defects at rest representing more than 20% of
the left ventricle, which might have influenced both the
evaluation of electrocardiographic and scintigraphic
changes.
In another report (19), performed in 11 patients without
prior myocardial infarction and nonoccluding LAD lesions,
resembling our population, neither the size nor the severity
of perfusion defects was correlated to the number of leads
with electrocardiographic changes. In contrast, by applying
dynamic vectorcardiographic registrations to the evaluation,
a significant correlation was observed between ST changes
and scintigraphic estimates of hypoperfusion. Although the
registration of electrocardiographic changes in our study
only represented a crude estimate of the overall electrocar-
diographic changes, there seemed to be a fairly good
correlation to the scintigraphic occlusion/rest count ratio.
The reason might be that both methods reflect changes of
perfusion in the microcirculation.
Our results suggest that scintigraphic estimates of myo-
cardial hypoperfusion can be used as an indicator of the
protective value of the recruitable collateral circulation
during coronary occlusion.
Methodological comments. A most crucial point for eval-
uating regional myocardial perfusion during brief episodes
of total occlusion of coronary arteries is probably related to
the amount of recirculating 99mTc-sestamibi in the blood
pool immediately after balloon deflation, at a time charac-
terized by reactive coronary hyperemia. In a previous study,
Wackers et al. (23) found that 36% and 23% of the injected
dose remained in the circulation 1 and 3 min, respectively,
after tracer injection. However, these figures relied on
venous blood sampling. According to the arterial plasma
profile of 99mTc-sestamibi (Fig. 4), we estimated the relative
630 Sand et al. JACC Vol. 35, No. 3, 2000
Mibi-SPECT and Recruitable Collaterals During PTCA March 1, 2000:624–32
amount of sestamibi available for uptake during the first 90 s
following tracer injection to be 68%. Thus, a substantial part
of the injected dose was present in the blood pool at the
time of balloon deflation. This potential limitation of exact
measurements of regional myocardial perfusion in our
model might be attenuated by a decreased extraction frac-
tion of sestamibi early after severe myocyte ischemia due to
electrochemical changes.
The possible time gap between the arterial peak concen-
tration of the tracer and the fully developed collateral
circulation might be of importance for the estimation of the
protective role of recruitable collaterals in our model. From
previous studies (24–26) it is known that coronary occlusion
is followed by a sequential process within the first 20 to 30 s,
including alterations of contractility, development of elec-
trocardiographic changes, and angina. The exact time at
which collaterals are fully recruited is unknown and may be
of critical importance for evaluating the protective role of
collaterals by sestamibi perfusion imaging. Arterial peak
concentration of 99mTc-sestamibi appeared approximately
25 s after injection. In one previous study (14) the tracer was
injected 20 s within the balloon occlusion and the range of
perfusion defect sizes (20% to 82%) during occlusion of the
proximal or mid-LAD resembled the values in our study.
Therefore, we believe that this is a minor limitation of our
study.
Photon scatter and reconstruction algorithms tend to
decrease the estimated scintigraphic severity of perfusion
defects, resulting in underestimation of truly existing hypo-
perfusion during balloon occlusion.
The inherent limitation related to the low resolution
(100 mm) of the angiographic procedure compared to the
size of collaterals might have influenced our results. The
classification of patients into those with and without collat-
erals was based on visible filling of the recipient artery rather
than visualization of the collateral circulation itself. Further,
all patients with scintigraphically mild hypoperfusion during
balloon occlusion had evidence of recruitable collateral
supply. Therefore, patients who had a substantial collateral
supply were likely not misclassified.
Study limitations. Evident limitations of this study are
related to the moderate number of patients with LAD
stenoses, which tend to diminish the statistical strength of
the study. In addition, ongoing antianginal medication
might have altered microcirculatory perfusion including the
collateral circulation.
The evaluation of collaterals/coronary wedge pressure and
regional hypoperfusion by sestamibi SPECT was performed
in two subsequent balloon dilations at the end of angio-
plasty. These balloon dilations most often represented
dilation 4 and 5. In the study by Pijls et al. (21) fractional
collateral blood flow was doubled between the first and
second inflation, but thereafter remained constant, indicat-
ing that no further recruitment of collaterals takes place
after the second inflation. Therefore, recruitment would not
be expected between inflation 4 and 5, and our estimations
of the functional capacity of collaterals probably represented
maximal achievable collateral supply. Undetected minor
differences in vascular tone of epicardial arteries between
subsequent balloon inflations in some patients cannot,
however, be excluded.
Study implications. The use of scintigraphy during coro-
nary occlusion should be seen as an additional method to
obtain insight about factors modifying regional perfusion
during coronary occlusion. The experimental setup used in
this study can be applied in most patients undergoing
PTCA without significant prolongation of the procedure,
and it may be useful for a number of investigational
purposes.
In the clinical setting, one previous study has shown that
indirect measures of the recruitable collateral status of
patients with one-vessel disease undergoing PTCA has
prognostic importance (21), and it therefore seems likely
that scintigraphic estimates of the functional capacity of the
collateral coronary supply might be a prognostic marker in
post-PTCA patients.
Conclusions. In a selected population with proximal LAD
stenosis, we found that patients with a substantial re-
cruitable collateral supply had significant less hypoperfusion
than did patients without collaterals during brief episodes of
coronary occlusion evaluated by 99mTc-sestamibi SPECT.
The scintigraphic estimate of hypoperfusion, the occlusion/
rest count ratio, was significantly correlated to the coronary
wedge pressure and ECG changes. Our results demonstrate
a protective role of recruitable collaterals on regional myo-
cardial perfusion during brief episodes of coronary occlu-
sion.
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